Majority of ovarian cancer cases are already at an advanced state at the time of diagnosis. Patients with advanced ovarian cancer typically eventually develop intraperitoneal carcinomatosis, for which cytoreductive surgery in combination with chemotherapy is considered standard treatment. However, additional treatment options are needed.
Models of intraperitoneal carcinomatosis are used in the preclinical evaluation of drug candidate efficacy. Fully immunocompetent models enable studying also immunomodulatory effects.
The HM-1 murine ovarian cancer cells are inoculated intraperitoneally in immunocompetent female mice to mimic the complexity of the tumor microenvironment of human peritoneal carcinomatosis. The model also involves build-up of ascites, which is typical for stage 3 and 4 ovarian cancer patients.
Pharmatest’s syngeneic mouse model offers an excellent tool to test your compound to treat ovarian cancer.
Contact an Expert
Headquarters, Research laboratories
Pharmatest Services Itäinen Pitkäkatu 4 A, 5th floor 20520 Turku FINLAND
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.